Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort-Reference-Cited by-同舟云学术

Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort

Published:2013-04-05 Issue:4 Volume:8 Page:e60613
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Smith David Hersi,Christensen Ib Jarle,Jensen Niels Frank,Markussen Bo,Rømer Maria Unni,Nygård Sune Boris,Müller Sven,Nielsen Hans Jørgen,Brünner Nils,Nielsen Kirsten Vang

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths;R Siegel;CA Cancer J Clin,2011

2. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale;G Colucci;J Clin Oncol,2005

3. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial;MT Seymour;Lancet,2007

4. Achille;C Tournigand;E,2004

5. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;RM Goldberg;J Clin Oncol,2004

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downstream-of-gene (DoG) transcripts contribute to an imbalance in the cancer cell transcriptome;Science Advances;2024-07-05

2. Downstream-of-gene (DoG) transcripts contribute to an imbalance in the cancer cell transcriptome;2024-01-02

3. Resistance to TOP-1 Inhibitors: Good Old Drugs Still Can Surprise Us;International Journal of Molecular Sciences;2023-04-13

4. Impact of Topoisomerases Complex Deregulation on Head and Neck Carcinoma Genomic Instability;Anticancer Research;2021-06

5. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features;Gastric Cancer;2019-04-15